Ads
related to: upadacitinib fda
Pharma Stock Roundup: FDA Decision Delays for PFE, LLY, ABBV, AZN Vaccine Woes
Zacks via Yahoo Finance· 2 weeks agoThis week the FDA announced delays in decisions on regulatory filings on atopic dermatitis JAK...
AbbVie (ABBV) Down as FDA Extends Review of Rinvoq sNDA
Zacks via Yahoo Finance· 1 month agoAbbVie ABBV announced that the FDA has extended the review period fora supplemental new drug...
Pharma Stock Roundup: J&J, AZN COVID-19 Update, FDA Delays Decision on ABBV's sNDA
Zacks via Yahoo Finance· 1 month agoAstraZeneca AZN announced a deal to supply additional doses of its potential COVID-19 antibody...
Pfizer's (PFE) Xeljanz Gets FDA Approval for 4th Indication
Zacks via Yahoo Finance· 7 months agoPfizer PFE announced that the FDA granted approval to its blockbuster drug, Xeljanz for its fourth...
AbbVie Seeks FDA Approval for Rinvoq in Ankylosing Spondylitis
Zacks via Yahoo Finance· 8 months agoAbbVie Inc. ABBV announced that it has submitted a regulatory application to the FDA for expanding...
Pharma Stock Roundup: ABBV's Rinvoq Gets FDA Nod, BAYRY to Sell Animal Health Unit
Zacks via Yahoo Finance· 2 years agoMeanwhile, Glaxo GSK, Pfizer PFE and AstraZeneca AZN provided pipeline and regulatory updates. FDA...
AbbVie's JAK Inhibitor Rinvoq Receives FDA Approval for RA
Zacks via Yahoo Finance· 2 years agoShares of AbbVie Inc. ABBV rose 2.3% on Aug 16 after its oral JAK inhibitor, upadacitinib, received ...
Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs
Zacks via Yahoo Finance· 1 year agoIn a busy week for the pharma sector ahead of the festive season, the FDA granted approval to...
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
Motley Fool via Yahoo Finance· 2 years agoOn Friday, AbbVie added another key FDA approval with a positive decision for Rinvoq (upadacitinib)...
Pharma Stock Roundup: LLY, NVS, AZN's Q3 Earnings, Updates From FDA
Zacks via Yahoo Finance· 1 year agoBristol-Myers BMY and Roche’s RHHBY PD-L1 inhibitors, Opdivo and Tecentriq, respectively, met their...
Ads
related to: upadacitinib fda
